Literature DB >> 28112816

Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.

Anna L Beavis1, Patti E Gravitt2, Anne F Rositch3.   

Abstract

BACKGROUND: The objectives of this study were to determine the age-standardized and age-specific annual US cervical cancer mortality rates after correction for the prevalence of hysterectomy and to evaluate disparities by age and race.
METHODS: Estimates for deaths due to cervical cancer stratified by age, state, year, and race were derived from the National Center for Health Statistics county mortality data (2000-2012). Equivalently stratified data on the prevalence of hysterectomy for women 20 years old or older from the Behavioral Risk Factor Surveillance System survey were used to remove women who were not at risk from the denominator. Age-specific and age-standardized mortality rates were computed, and trends in mortality rates were analyzed with Joinpoint regression.
RESULTS: Age-standardized rates were higher for both races after correction. For black women, the corrected mortality rate was 10.1 per 100,000 (95% confidence interval [CI], 9.6-10.6), whereas the uncorrected rate was 5.7 per 100,000 (95% CI, 5.5-6.0). The corrected rate for white women was 4.7 per 100,000 (95% CI, 4.6-4.8), whereas the uncorrected rate was 3.2 per 100,000 (95% CI, 3.1-3.2). Without the correction, the disparity in mortality between races was underestimated by 44%. Black women who were 85 years old or older had the highest corrected rate: 37.2 deaths per 100,000. A trend analysis of corrected rates demonstrated that white women's rates decreased at 0.8% per year, whereas the annual decrease for black women was 3.6% (P < .05).
CONCLUSIONS: A correction for hysterectomy has revealed that cervical cancer mortality rates are underestimated, particularly in black women. The highest rates are seen in the oldest black women, and public health efforts should focus on appropriate screening and adequate treatment in this population. Cancer 2017;123:1044-50.
© 2016 American Cancer Society. © 2017 American Cancer Society.

Entities:  

Keywords:  Behavioral Risk Factor Surveillance System; Epidemiology; Surveillance; and End Results (SEER); cervical cancer; disparities; hysterectomy; mortality

Mesh:

Year:  2017        PMID: 28112816     DOI: 10.1002/cncr.30507

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  57 in total

1.  Human Papillomavirus Vaccination Initiation Among Sexual Orientation Identity and Racial/Ethnic Subgroups of Black and White U.S. Women and Girls: An Intersectional Analysis.

Authors:  Madina Agénor; Ashley E Pérez; Sarah M Peitzmeier; Jennifer Potter; Sonya Borrero
Journal:  J Womens Health (Larchmt)       Date:  2018-06-29       Impact factor: 2.681

2.  Smoking Cessation Treatment Needs of Low SES Cervical Cancer Survivors.

Authors:  Diana S Hoover; Claire A Spears; Damon J Vidrine; Joan L Walker; Ya-Chen Tina Shih; David W Wetter
Journal:  Am J Health Behav       Date:  2019-05-01

3.  Medicaid Expansions and Cervical Cancer Screening for Low-Income Women.

Authors:  Lindsay M Sabik; Wafa W Tarazi; Stephanie Hochhalter; Bassam Dahman; Cathy J Bradley
Journal:  Health Serv Res       Date:  2017-06-30       Impact factor: 3.402

4.  The Impact of Racial, Geographic, and Socioeconomic Risk Factors on the Development of Advanced-Stage Cervical Cancer.

Authors:  T Clark Powell; Sarah E Dilley; Sejong Bae; J Michael Straughn; Kenneth H Kim; Charles A Leath
Journal:  J Low Genit Tract Dis       Date:  2018-10       Impact factor: 1.925

5.  Taking an HPV vaccine research-tested intervention to scale in a clinical setting.

Authors:  Suellen Hopfer; Anne E Ray; Michael L Hecht; Michelle Miller-Day; Rhonda Belue; Gregory Zimet; W Douglas Evans; Francis X McKee
Journal:  Transl Behav Med       Date:  2018-09-08       Impact factor: 3.046

6.  Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.

Authors:  Michelle I Silver; Anne F Rositch; Darcy F Phelan-Emrick; Patti E Gravitt
Journal:  Cancer Causes Control       Date:  2017-11-09       Impact factor: 2.506

7.  Women with cancer in low-income countries.

Authors:  S A Narod
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

8.  HPV Self-Sampling for Cervical Cancer Screening Among Ethnic Minority Women in South Florida: a Randomized Trial.

Authors:  Olveen Carrasquillo; Julia Seay; Anthony Amofah; Larry Pierre; Yisel Alonzo; Shelia McCann; Martha Gonzalez; Dinah Trevil; Tulay Koru-Sengul; Erin Kobetz
Journal:  J Gen Intern Med       Date:  2018-03-28       Impact factor: 5.128

9.  Closing the cervical cancer disparity gap.

Authors:  Patricia J Kelly; Megha Ramaswamy
Journal:  Public Health Nurs       Date:  2017-05       Impact factor: 1.462

10.  Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.

Authors:  Alison L Van Dyke; Meredith S Shiels; Gieira S Jones; Ruth M Pfeiffer; Jessica L Petrick; Jennifer L Beebe-Dimmer; Jill Koshiol
Journal:  Cancer       Date:  2019-01-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.